Cassia Capital Partners LLC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 621 shares of the biopharmaceutical company’s stock after buying an additional 32 […]
Hudson Canyon Capital Management lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,626 shares of the biopharmaceutical company’s stock after selling 57 shares during the quarter. Regeneron Pharmaceuticals makes […]
Stiles Financial Services Inc increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 12.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,033 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the […]
Valley National Advisers Inc. raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,394 shares of the biopharmaceutical company’s stock after purchasing an additional 24 shares during the quarter. Valley […]
DekaBank Deutsche Girozentrale lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 224,185 shares of the biopharmaceutical company’s stock after purchasing an additional 23,795 shares during the […]